Abrocitinib group:None

2 trials

Sponsors

Jining First People's Hospital, Xiangya Hospital of Central South University

Conditions

Atopic Dermatitisatopic dermatitis

Phase 4

Clinical Efficacy and Safety Analysis of Janus Kinase Inhibitor in the Treatment of Moderate to Severe Atopic Dermatitis

ChiCTR2300071142

Jining First People's HospitalAtopic Dermatitis

Start: 2023-05-01Updated: 2023-11-27

Study on biomarkers of targeted therapy for atopic dermatitis

RecruitingChiCTR2300076625

Xiangya Hospital of Central South Universityatopic dermatitis

Start: 2022-01-01Updated: 2023-10-16